Tamar Peretz

12.8k total citations · 2 hit papers
278 papers, 8.8k citations indexed

About

Tamar Peretz is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Tamar Peretz has authored 278 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 144 papers in Oncology, 88 papers in Molecular Biology and 56 papers in Cancer Research. Recurrent topics in Tamar Peretz's work include BRCA gene mutations in cancer (41 papers), Cancer Genomics and Diagnostics (36 papers) and Proteoglycans and glycosaminoglycans research (25 papers). Tamar Peretz is often cited by papers focused on BRCA gene mutations in cancer (41 papers), Cancer Genomics and Diagnostics (36 papers) and Proteoglycans and glycosaminoglycans research (25 papers). Tamar Peretz collaborates with scholars based in Israel, United States and Germany. Tamar Peretz's co-authors include Israël Vlodavsky, Michael Elkin, Eyal Zcharia, Lea Baider, Albert Grinshpun, Ayala Hubert, Tamar Hamburger, Benjamin Nisman, Ruth Atzmon and Luna Kadouri and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Tamar Peretz

273 papers receiving 8.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

1995 512 citations Tamar Peretz et al. profile →
Life and death of circulating cell-free DNA

2019 404 citations Tamar Peretz, Albert Grinshpun et al. Cancer Biology & Therapy profile →

Peers

Countries citing papers authored by Tamar Peretz

Since Specialization

Citations

This map shows the geographic impact of Tamar Peretz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamar Peretz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamar Peretz more than expected).

Fields of papers citing papers by Tamar Peretz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamar Peretz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamar Peretz. The network helps show where Tamar Peretz may publish in the future.

Co-authorship network of co-authors of Tamar Peretz

This figure shows the co-authorship network connecting the top 25 collaborators of Tamar Peretz. A scholar is included among the top collaborators of Tamar Peretz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamar Peretz. Tamar Peretz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preventing skin toxicities induced by EGFR inhibitors by topically blocking drug-receptor interactions 2023 ·Science Translational Medicine ·(unknown), Liza Weinstein‐Fudim, (unknown), (unknown), (unknown), (unknown), Shoshana Frankenburg, Tamar Peretz, Galit Eisenberg, Michal Lotem, Ofra Benny, Sharon Merims	0
2	Rapid Classification of Sarcomas Using Methylation Fingerprint: A Pilot Study 2023 ·Cancers ·(unknown), Myriam Maoz, (unknown), (unknown), Omer Or, (unknown), (unknown), Mohammad Adileh, Marc Wygoda, (unknown), (unknown), (unknown), Joshua Moss, Tamar Peretz, Amir Eden, Aviad Zick, Iris Lavon	3
3	Multiplexed, single-molecule, epigenetic analysis of plasma-isolated nucleosomes for cancer diagnostics 2022 ·Nature Biotechnology ·(unknown), (unknown), Noa Furth, (unknown), Ekaterina N. Andreishcheva, (unknown), Daniel Jones, Barak Bar Zakai, (unknown), Tamar Peretz, Ayala Hubert, Jonathan Cohen, Azzam Salah, Mark Temper, Albert Grinshpun, Myriam Maoz, Aviad Zick, G. Ron, Efrat Shema	56
4	Alternative Splicing of the Inhibitory Immune Checkpoint Receptor SLAMF6 Generates a Dominant Positive Form, Boosting T-cell Effector Functions 2021 ·Cancer Immunology Research ·Emma Hajaj, (unknown), (unknown), Sharon Merims, Jonathan Cohen, Shiri Klein, Shoshana Frankenburg, Moshe Sade-Feldman, Yuval Tabach, Keren Yizhak, Ami Navon, Polina Stepensky, Nir Hacohen, Tamar Peretz, André Veillette, Rotem Karni, Galit Eisenberg, Michal Lotem	14
5	Homologous recombination in lung cancer, germline and somatic mutations, clinical and phenotype characterization 2019 ·Lung Cancer ·Luna Kadouri, Yakir Rottenberg, Aviad Zick, Tamar Hamburger, Doron Lipson, Tamar Peretz, Hovav Nechushtan	23
6	Heparanase Accelerates Obesity-Associated Breast Cancer Progression 2019 ·Cancer Research ·Esther Hermano, Rachel Goldberg, Ariel M. Rubinstein, Amir Sonnenblick, Bella Maly, (unknown), Jinping Li, Marinka A.H. Bakker, Johan van der Vlag, Israël Vlodavsky, Tamar Peretz, Michael Elkin	26
7	Clinical Proteomics of Breast Cancer Reveals a Novel Layer of Breast Cancer Classification 2018 ·Cancer Research ·(unknown), (unknown), Michal Harel, Amir Sonnenblick, Tamar Peretz, Tamar Geiger	60
8	Soluble SLAMF6 Receptor Induces Strong CD8+ T-cell Effector Function and Improves Anti-Melanoma Activity In Vivo 2018 ·Cancer Immunology Research ·Galit Eisenberg, (unknown), (unknown), Emma Hajaj, Sharon Merims, Shoshana Frankenburg, (unknown), (unknown), Arthur Machlenkin, (unknown), Tamar Peretz, Michal Lotem	19
9	Ev vivo organ culture as potential prioritization tool for breast cancer targeted therapy 2018 ·Cancer Biology & Therapy ·Albert Grinshpun, Nancy Gavert, Roy Z. Granit, (unknown), Ittai Ben‐Porath, (unknown), Aviad Zick, Shai Rosenberg, Myriam Maoz, (unknown), Eli Pikarsky, (unknown), Tamar Peretz, Amir Sonnenblick	6
10	Potent Activation of Human T Cells by mRNA Encoding Constitutively Active CD40 2018 ·The Journal of Immunology ·Noam Levin, (unknown), (unknown), Orit Itzhaki, Michal J. Besser, Galit Eisenberg, Tamar Peretz, Michal Lotem, Gideon Gross	12
11	Retrospective Study of the Predictive Value of Target Now in Systemic Therapy for Metastatic Colorectal and Gastric Carcinomas. 2015 ·PubMed ·Jonathan Cohen, (unknown), Tamar Peretz, Ayala Hubert	1
12	The prognostic significance of LIAISON(R) CA15-3 assay in primary breast cancer. 2013 ·PubMed ·Benjamin Nisman, Ofra Maimon, Tanir M. Allweis, Luna Kadouri, Bella Maly, Tamar Hamburger, Tamar Peretz	11
13	[Update: adjuvant trastuzumab in HER2 positive breast cancer]. 2012 ·PubMed ·Esther Tahover, Amir Sonnenblick, Tamar Peretz, Daniela Katz	1
14	Role of Heparanase in Radiation-Enhanced Invasiveness of Pancreatic Carcinoma 2011 ·Cancer Research ·Amichay Meirovitz, Esther Hermano, Immanuel Lerner, Eyal Zcharia, Claudio Pisano, Tamar Peretz, Michael Elkin	61
15	Function of Heparanase in Prostate Tumorigenesis: Potential for Therapy 2008 ·Clinical Cancer Research ·Immanuel Lerner, (unknown), Eli Pikarsky, Amichay Meirovitz, Evgeny Edovitsky, Tamar Peretz, Israël Vlodavsky, Michael Elkin	62
16	Role of endothelial heparanase in delayed-type hypersensitivity 2005 ·Blood ·Evgeny Edovitsky, Immanuel Lerner, Eyal Zcharia, Tamar Peretz, Israël Vlodavsky, Michael Elkin	126
17	[Screening mammography for early diagnosis of breast cancer: facts, controversies, and the implementation in Israel]. 2003 ·PubMed ·Tanir M. Allweis, Aviram Nissan, Ram M. Spira, Miri Sklair‐Levy, Herbert R. Freund, Tamar Peretz	4
18	Regulation of heparanase gene expression by estrogen in breast cancer. 2003 ·PubMed ·Michael Elkin, (unknown), Eyal Zcharia, (unknown), (unknown), Tamar Peretz, Israël Vlodavsky, Hynda K. Kleinman	94
19	CMF (Cyclophosphamide, Methotrexate, 5-Fluorouracil) Versus CNF (Cyclophosphamide, Mitoxantrone, 5-Fluorouracil) as Adjuvant Chemotherapy for Stage II Lymph-Node Positive Breast Cancer 2002 ·American Journal of Clinical Oncology ·Ilan G. Ron, Nely Wigler, Riva Borovik, Tamar Peretz, Shulamith Rizel, Adi Shani, Joseph Brenner, (unknown), Harold J. Brenner, Samario Chaitchik, Raphael Catane, Moshe Inbar	1
20	Maintenance on extracellular matrix and expression of heparanase activity by human ovarian carcinoma cells from biopsy specimens 1990 ·International Journal of Cancer ·Tamar Peretz, (unknown), Uziel Beller, Aviva T. Horowitz, Zvi Fuks, Israël Vlodavsky	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact